Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2022.762307
Abstract: Achromobacter genus (including Achromobacter xylosoxidans, the most prevalent Achromobacter species in patients with cystic fibrosis) is poorly susceptible to most conventional antibiotics. Contribution of efflux by AxyABM, AxyXY-OprZ, and AxyEF-OprN and of target mutations were…
read more here.
Keywords:
achromobacter xylosoxidans;
patients cystic;
xylosoxidans achromobacter;
achromobacter ... See more keywords